David M Mott bought $1.9M of ARDX
director at ARDELYX, INC.. 333,333 shares at an average of $5.84, traded Feb 20, 2026, filed Feb 23, 2026.
Score components
- +15RoleDirector
- +25Trade size$1.9M at market
- +3Relative to holdingsHoldings up 11%
- +4Price context28% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (1 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -1.9%, 3m +6.3%, 6m -35.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001610717-26-000066, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 20, 2026 | POpen-market purchase Common Stock | +333,333 | $5.84 | $1.9M | 3,302,918 | Feb 23, 2026 |
Related signals
Other insiders at ARDELYX, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | ARDELYX, INC. | John E Bishop See Remarks | $76k 19,750 shares | -6% | |
| 53Moderate | ARDELYX, INC. | Michael Raab President & CEO | $226k 58,574 shares | -3% | |
| 36Weak | ARDELYX, INC. | Laura A Williams Chief Patient Officer | $41k 10,739 shares | -3% | |
| 35Weak | ARDELYX, INC. | Mike Kelliher Chief Business Officer | $30k 7,758 shares | -2% | |
| 36Weak | ARDELYX, INC. | Eric Duane Foster Chief Commercial Officer | $33k 8,562 shares | -2% | |
| 30Weak | ARDELYX, INC. | Joseph James Reilly See Remarks | $15k 3,982 shares | -3% | |
| 37Weak | ARDELYX, INC. | James Parker Brady Chief Human Resources Officer | $58k 15,136 shares | -6% | |
| 37Weak | ARDELYX, INC. | Susan Hohenleitner Chief Financial Officer | $6,009 1,558 shares | -1% | |
| 2Weak | ARDELYX, INC. | Michael Raab President & CEO | $211k 41,668 shares | -2% | |
| 11Weak | ARDELYX, INC. | Laura A Williams Chief Patient Officer | $490k 81,898 shares | -18% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.